Correlation Between Keros Therapeutics and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Keros Therapeutics and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Zentalis Pharmaceuticals.
Diversification Opportunities for Keros Therapeutics and Zentalis Pharmaceuticals
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Keros and Zentalis is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Keros Therapeutics and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Keros Therapeutics is expected to under-perform the Zentalis Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Keros Therapeutics is 2.33 times less risky than Zentalis Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Zentalis Pharmaceuticals Llc is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 283.00 in Zentalis Pharmaceuticals Llc on August 29, 2024 and sell it today you would earn a total of 65.00 from holding Zentalis Pharmaceuticals Llc or generate 22.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Keros Therapeutics vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Keros Therapeutics |
| Zentalis Pharmaceuticals |
Keros Therapeutics and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Keros Therapeutics and Zentalis Pharmaceuticals
The main advantage of trading using opposite Keros Therapeutics and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
| Zentalis Pharmaceuticals vs. Eliem Therapeutics | Zentalis Pharmaceuticals vs. Scpharmaceuticals | Zentalis Pharmaceuticals vs. Milestone Pharmaceuticals | Zentalis Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |